FDA OKs Another Monoclonal Antibody to Protect Against RSV in Infants

(MedPage Today) – Merck’s pharmaceutical maker announced on Monday that “ENFLONSIA” to prevent low respiratory disease from the respiratory virus (RSV) in infants born during or enter the first RSV season … length …